All News
View More
What Does Pear Therapeutics’ Bankruptcy Mean for PDTs?

The company paved the way for prescription digital therapeutics.

No Concerning Side Effects Found in Young Children Who Received the COVID-19 Vaccine

Weekly surveillance monitoring, also known as rapid cycle analysis, of more than 245,000 COVID-19 mRNA vaccine doses did not detect a safety signal for any outcome 21 days after vaccination.

Over 7,000 Walmart Pharmacists and Opticians Receiving Raises, Career Development Opportunities

The retail giant’s initiative to offer attractive pay in every market they operate reflects in the pay raise of all associates. The average salary for pharmacists is now more than $140,000, not including bonuses and incentives. After investments within the optician and vision department, it’s expected the average wage for opticians to be more than $22.50 an hour.

Capital Blue Cross Members are Benefiting from Diabetes Management and Prevention Programs

Eligible members can enroll into these programs through Virta and Omada Health tools under Capital. The programs are personalized for Capital members on an easy-to-use app offering one-on-one health coaching, medical tools, community support, activity tracking and more.

CMS Will Cover Alzheimer’s Drugs Leqembi, Donanemab — With Strings Attached

The drugs must have full “traditional” FDA approval and patients need to be enrolled in a registry that collects post-approval data efficacy and safety when the drugs are used in clinical practice.

The Risk of Developing Childhood Asthma Is Lower if a Child Was Not Infected With RSV as an Infant

Understanding whether the prevention of RSV infection during infancy can reduce the risk of childhood asthma is key to designing successful and preventive strategies, preventing long-term childhood respiratory morbidity, and outlining healthcare policy measures.

UnitedHealth Ditches Controversial Prior Authorization for GI Procedures for ‘Advance Notification Process’

The head of a gastroenterologist group criticizes the company for having a "slapdash approach."

Biosimilars Fail to Deliver on Insulin Pricing

Bowing to political and public pressure, insulin makers have slashed their prices. So far, insulin biosimilars haven’t had much of an effect on prices.

Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's September Issue

Editors are searching for diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests, and so on. Candidates should have, but not limited to, 12 years or fewer experience in healthcare.

Official Media Partners

PBMI logo

Join the Community

an mjh life sciences brand

© 2022 MJH Life Sciences® and PBMI. All rights reserved.